Environment
Day after day, we work hard and strive to make a positive impact on the environment.
read more
Ensuring a sustainable supply chain for antibiotics
Combatting AMR means looking beyond our immediate horizons and working as part of the wider pharmaceutical value chain to effect change.
Read more
Story
Story
Story
Story
For the fifth year in a row, Centrient Pharmaceuticals* Receives 2024 Gold Sustainability Rating from EcoVadis
read more
Centrient Pharmaceuticals Receives Gold Sustainability Rating from EcoVadis
read more
STEM programme
We are working to raise awareness of antimicrobial resistance (AMR), and establish best practice in the regions where it’s needed most.
read more
AMR IA framework on responsible antibiotic manufacturing
Centrient has been working closely with the other AMR Industry Alliance members to create the first common framework for responsible antibiotic manufacturing.
read moreESG report 2024
Sustainability is at the heart of our daily decisions and integral to our strategic vision leading up to 2030. It underscores our purpose of enhancing the well-being of patients worldwide. In navigating the complex landscape of choices, we focus on areas where our actions can exert the greatest influence.
Read more
ESG Reporting
Click on the link to download the report
